🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10402+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10402 recruiting trials

Phase 2RecruitingNCT06868628

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

🏥 Tiziana Life Sciences LTD📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06977269

Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy

👨‍⚕️ Olena V Pisotska, MD, PhD, P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07149675

PBC Long-term Outcomes Study

🏥 Beijing Friendship Hospital📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06943378

Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults

🏥 Just-Evotec Biologics📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06849713

Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL

👨‍⚕️ Jacob Soumerai, MD, Massachusetts General Hospital📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06641726

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

👨‍⚕️ Prof. James Walters, Cardiff University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06940531

Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis

🏥 Alexander Horsley📍 18 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06676774

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

👨‍⚕️ Mirjam Christ-Crain, Prof. Dr., University Hospital, Basel, Switzerland📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT07162688

Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.

👨‍⚕️ Ting Yang, MD, PhD, First Affiliated Hospital of Fujian Medical University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07362875

Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy

👨‍⚕️ Araya Puwanant, MD, Wake Forest University Health Sciences📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06762795

The HIEnome Study: Genome Sequencing for Perinatal HIE

🏥 Baylor College of Medicine📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06909253

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

🏥 AstraZeneca📍 14 sites📅 Started May 2025View details ↗
NARecruitingNCT07332702

Long Read Analysis in Spinal Muscular Atrophy - LOREASI

👨‍⚕️ Pascale Saugier-Veber, PharmD PhD📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07312305

Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)

🏥 University of Milan📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06597240

Home Monitoring During Chemoradiation

👨‍⚕️ Rudolf S.N. Fehrmann, MD, PhD, University Medical Center Groningen📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT05485155

Zemaira Eosinophilic Esophagitis Pilot Study

👨‍⚕️ Marc Rothenberg, Cincinnati Children's Hospital Medical Center📍 2 sites📅 Started May 2025View details ↗
NARecruitingNCT06298474

The BRAIN App (Phase 2 SBIR)

🏥 Hopeful Aging📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06282016

Risk Factors for Neuroendocrine Neoplasms

👨‍⚕️ Jacqueline Müller-Nordhorn, Bavarian Cancer Registry, Bavarian Health and Food Safety Authority📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07348263

EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

🏥 Meyer Children's Hospital IRCCS📍 15 sites📅 Started May 2025View details ↗
Enrolling by InvitationNCT06717932

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

🏥 CorrectSequence Therapeutics Co., Ltd📍 1 site📅 Started May 2025View details ↗
← PreviousPage 110 of 521Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →